Activities of advertising agencies
IMMUNOPHARMA AS
Revenue 2024
NOK 12.2m
Operating profit
NOK −38.5m
Equity
NOK 209.0m
Incorporated
2009
Employees
13
Share capital
NOK 13.9m
Financials
Total operating revenue
Operating profit (EBIT)
Income statement
| Post | 2024 | Trend |
|---|---|---|
| Total operating revenue | 12.2m | |
| Total operating costs | 50.7m | |
| Operating profit (EBIT) | −38.5m | |
| Net financial items | 57.2m | |
| Profit for the year | 13.7m |
Balance sheet
| Post | 2024 | Trend |
|---|---|---|
| Total assets | 338.1m | |
| of which current assets | 72.7m | |
| Equity | 209.0m | |
| Total liabilities | 129.1m |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.